MedPath

Polymer used in the Treatment of Stress Incontinence in Women.

Not Applicable
Conditions
rinary incontinence
urine leaks.
N39.3
Registration Number
RBR-46xb4bm
Lead Sponsor
niversidade Federal de Pernambuco
Brief Summary

The study considered as primary outcome the improvement or disappearance of symptoms after six months of intervention. Post-intervention Quality of Life (QOL) questionnaire indicated that all of these patients related a better quality of life (62.5 %).

Detailed Description

Not available

Recruitment & Eligibility

Status
Data analysis completed
Sex
Female
Target Recruitment
Not specified
Inclusion Criteria

Female volunteers; diagnosis of stress urinary incontinence; no history of previous surgery.

Exclusion Criteria

Volunteers with previous diagnosis of infravesical obstruction of a mechanical nature; previous diagnosis of neurogenic bladder, presence of urethral hypermobility.

Study & Design

Study Type
Intervention
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Reduction of urinary loss on exertion, verified through the ICIQ-SF;<br>PAD-Test Quality of Life questionnaire, after analyzing the results in the pre and post-intervention moments.;Significant improvement and disappearance of urinary loss symptoms six months after the intervention. <br>The Quality of Life (QOL) questionnaire at the time of the intervention indicated that all patients reported a better quality of life (62.5%). <br>Through the PAD-test it was possible to observe a decrease in urinary loss of 85% comparing the pre and post-intervention results (BCA - Bacterial Cellulose Application) with a p-value equal to 0.000009.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath